Core Viewpoint - U.S. Physical Therapy, Inc. will report its financial results for Q4 and the full year of 2025 on February 25, 2026, after market close, with a conference call scheduled for the following morning [1] Financial Reporting - The financial results will cover the fourth quarter and the entire year ending December 31, 2025 [1] - The announcement of the results will occur after the stock market closes on February 25, 2026 [1] - A conference call to discuss the results will take place on February 26, 2026 [1]

Core Insights - U.S. Physical Therapy, Inc. is a national operator of outpatient physical therapy clinics and provides industrial injury prevention services [1] - The company was founded in 1990 and currently owns and/or manages 780 outpatient physical therapy clinics [1] Company Presentation - Chris Reading, the Chief Executive Officer, presented at the J.P. Morgan 2026 Healthcare Conference on January 14, 2026 [1]

Core Insights - 4D Advisors has initiated a new position in U.S. Physical Therapy by acquiring 110,000 shares valued at $9.34 million as of September 30, 2025, indicating strong confidence in the company despite recent stock price declines [2][11]. Company Overview - U.S. Physical Therapy operates 591 clinics across 39 states, providing outpatient physical therapy and industrial injury prevention services, which include rehabilitation and ergonomic assessments [7][10]. - The company reported trailing twelve months (TTM) revenue of $758.71 million and net income of $36.02 million, with a dividend yield of 2.5% [5][10]. Financial Performance - As of November 14, 2025, U.S. Physical Therapy's stock price was $71.67, reflecting an 18.75% decline over the past year, underperforming the S&P 500 by 32.75 percentage points [3][12]. - Revenue for the first three quarters of 2025 reached $578.3 million, up from $490.9 million in 2024, indicating growth in sales [12]. Investment Position - The new position in U.S. Physical Therapy represents 4.97% of 4D Advisors' 13F reportable assets under management, making it the third largest holding in the fund [3][11]. - The price-to-earnings ratio for U.S. Physical Therapy has decreased from over 85 in Q3 of the previous year to approximately 32 in 2025, suggesting a potentially attractive valuation for investors [13].